CytoSorbents receives Nasdaq non-compliance notice for MVLS below $35M

Cytosorbents Corp

Received Nasdaq notice on June 29, 2026 for failing MVLS requirement (minimum $35M).
Has 180 days, until Dec 28, 2026, to regain compliance by meeting $35M for 10 consecutive business days.
May also consider increasing stockholders' equity to at least $2.5 million as alternative.
Notice does not immediately delist; company evaluating options to regain compliance.
No assurance of maintaining Nasdaq listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.